Product Images Losartan Potassium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Losartan Potassium NDC 71610-082 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Bottle Label 50 mg - 71610 0082 60
Losartan potassium is a medication commonly used to treat high blood pressure. This package contains 90 tablets, each containing 50mg of losartan potassium. The NOC number, THETOaRR %0, is not recognizable and its meaning is not available.*
Aphena Pharma Solutions - TN - Aphena
Figure 1 - losartan fig1
The given text provides some statistical data related to two medicines, Atenolol and Losartan Potassium, in terms of patients with primary endpoint. The adjusted risk reduction percentage and p-value for these medicines are also given. The timeline of the study is mentioned on the bottom with study months ranging from 6 to 66.*
Figure 2 - losartan fig2
This is a not-available description which seems to include medication names - Atenolol and Losartan Potassium. There is also mention of "patients with fatal/non-fat" and "Adjusted Risk Reduction" of 25% with a p-value of 0.001. The text also shows a timeline from 0 to 66 Study Months. However, it is not clear what context this information is referring to.*
Figure 3 - losartan fig3
The text provided is not usable or readable. The output is garbled and contains many gibberish or broken words and characters.*
Figure-4 - losartan fig4
The text displays the results of a clinical trial comparing the effects of Losttan Potassium versus a placebo on patients. The first line shows the percentage of patients who experienced an event (unspecified), with 60% of those treated with Losttan Potassium having experienced the event and 40% of those receiving the placebo experiencing the event. The next line reports that there was a 16.1% risk reduction for those taking Losttan Potassium compared to the placebo. The final line shows a mathematical equation comparing Losttan Potassium and the placebo. The text does not contain more information to provide a more specific explanation of the study.*
Chemical Structure - losartan str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.